2016 International Congress Archives - Page 23 of 207

12:00pm-1:30pm: Expiratory muscle training for the impaired loudness of speech in Parkinson’s disease: An open-label study

S. Tomita, T. Oeda, A. Umemura, M. Kohsaka, K. Park, K. Yamamoto, H. Sugiyama, H. Sawada (Kyoto, Japan)

Parkinson's disease: Clinical trials, pharmacology and treatment · Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm: Exploratory efficacy of opicapone in fluctuating Parkinson’s disease patients at different stages of symptom progression

N. Lopes, J. Ferreira, A. Lees, W. Poewe, H. Reichmann, A. Santos, C. Oliveira, J.F. Rocha, P. Soares-da-Silva (Porto, Portugal)

Parkinson's disease: Clinical trials, pharmacology and treatment · Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm: Exploring hospitalizations and visits to the emergency room of patients with Parkinson’s disease: A ten years’ follow-up

M.T. Montojo, Y. Macias, M. ÁLvarez, C. Martín, L. Borrega, L. Vela (Alcorcón, Spain)

Other · Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm: Exploring therapeutic viability of a non-dopaminergic target for Parkinson’s disease

A. Ashrafi, M. Buttini, P. Garcia, A. del Sol, E. Glaab (Esch-sur-Alzette, Luxembourg)

Parkinson's disease: Clinical trials, pharmacology and treatment · Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm: Extended-release carbidopa-levodopa, IPX066: Dosing and efficacy with concomitant medication use in Parkinson’s disease

S. Gupta, S. Khanna, S. Kell, R. Rubens (Hayward, CA, USA)

Parkinson's disease: Clinical trials, pharmacology and treatment · Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm: Factors affecting the cardiac sympathetic denervation in autopsy confirmed dementia with Lewy bodies

M. Takahashi, T. Uchihara, M. Yoshida, K. Wakabayashi, A. Kakita, H. Takahashi, S. Toru, T. Kobayashi, S. Orimo (Tokyo, Japan)

Other · Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm: Factors associated with falling in early, treated Parkinson’s disease: The NET-PD LS1 cohort

K.L. Chou, J.J. Elm, C.L. Wielinski, D.K. Simon, M.J. Aminoff, C.W. Chadwick, G.S. Liang, R.A. Hauser, L. Sudarsky, C.C. Umeh, T. Voss, J. Juncos, J.Y. Fang, J.T. Boyd, I. Bodis-Wollner, M. Zoltan, J.C. Morgan, A.M. Wills, S.L. Lee, S.A. Parashos, On behalf of the NINDS NET-PD Investigators (Ann Arbor, MI, USA)

Parkinsons's Disease: Clinical Trials I

12:00pm-1:30pm: Fall status and stepping response: Individuals with PD are differently influenced by side-affected

B.N. Intzandt, E. Beck, M.P. Pereira, Q.J. Almeida (Waterloo, ON, Canada)

Other · Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm: Falls and frailty predicate escalating care needs in Parkinson’s disease

B. Mohamed, C. Thomas, H. Shukla, S. Aithal (Cardiff, United Kingdom)

Parkinson's disease: Clinical trials, pharmacology and treatment · Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm: Familial cortical myoclonic tremor with epilepsy in Chinese population: Clinical and neurophysiologic features in nine pedigrees from People’s Republic of China

Z. Cen, C. Huang, H. Yin, F. Xie, X. Lu, Z. Ouyang, Y. Lou, X. Qiu, Z. Wang, J. Xiao, M. Ding, W. Luo (Hangzhou, People's Republic of China)

Clinical trials and therapy in movement disorders · Exhibit Hall located in Hall B, Level 2